CPG23STEM

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameCPG23STEM
Drug Alias Nameumbilical cord stem cell therapy (Celprogen)CPG23STEM
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Umbilical cord stem cell therapy
Mechanisms of ActionInsulin release stimulants
TargetsInsulin receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 1
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCelprogen
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCelprogen
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 1

Other Information

ATC CodeN/A
Related LinksN/A